BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 33897465)

  • 1. Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab.
    Altomare C; Lodrini AM; Milano G; Biemmi V; Lazzarini E; Bolis S; Pernigoni N; Torre E; Arici M; Ferrandi M; Barile L; Rocchetti M; Vassalli G
    Front Physiol; 2021; 12():658790. PubMed ID: 33897465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity.
    Milano G; Biemmi V; Lazzarini E; Balbi C; Ciullo A; Bolis S; Ameri P; Di Silvestre D; Mauri P; Barile L; Vassalli G
    Cardiovasc Res; 2020 Feb; 116(2):383-392. PubMed ID: 31098627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin and trastuzumab regimen induces biventricular failure in mice.
    Milano G; Raucci A; Scopece A; Daniele R; Guerrini U; Sironi L; Cardinale D; Capogrossi MC; Pompilio G
    J Am Soc Echocardiogr; 2014 May; 27(5):568-79. PubMed ID: 24534652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Evidence of MSCs-Derived Exosomes in Doxorubicin/Trastuzumab-Induced Cardiotoxicity: Beyond Mechanistic Target of NRG-1/Erb Signaling Pathway.
    Ebrahim N; Al Saihati HA; Mostafa O; Hassouna A; Abdulsamea S; Abd El Aziz M El Gebaly E; Abo-Rayah NH; Sabry D; El-Sherbiny M; Madboly AG; Hussien NI; Saadani REH; Ebrahim HA; Badr OAM; Elsherbiny NM; Salim RF
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overweight in mice, induced by perinatal programming, exacerbates doxorubicin and trastuzumab cardiotoxicity.
    Guenancia C; Hachet O; Aboutabl M; Li N; Rigal E; Cottin Y; Rochette L; Vergely C
    Cancer Chemother Pharmacol; 2016 Apr; 77(4):777-85. PubMed ID: 26914236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity.
    Akolkar G; Bhullar N; Bews H; Shaikh B; Premecz S; Bordun KA; Cheung DY; Goyal V; Sharma AK; Garber P; Singal PK; Jassal DS
    Cardiovasc Ultrasound; 2015 Apr; 13():18. PubMed ID: 25889218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cardioprotective Role of Flaxseed in the Prevention of Doxorubicin- and Trastuzumab-Mediated Cardiotoxicity in C57BL/6 Mice.
    Asselin CY; Lam A; Cheung DYC; Eekhoudt CR; Zhu A; Mittal I; Mayba A; Solati Z; Edel A; Austria JA; Aukema HM; Ravandi A; Thliveris J; Singal PK; Pierce GN; Niraula S; Jassal DS
    J Nutr; 2020 Sep; 150(9):2353-2363. PubMed ID: 32510147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardioprotective role of probucol against anthracycline and trastuzumab-mediated cardiotoxicity.
    Walker JR; Sharma A; Lytwyn M; Bohonis S; Thliveris J; Singal PK; Jassal DS
    J Am Soc Echocardiogr; 2011 Jun; 24(6):699-705. PubMed ID: 21353471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cardioprotective Role of N-Acetyl Cysteine Amide in the Prevention of Doxorubicin and Trastuzumab-Mediated Cardiac Dysfunction.
    Goyal V; Bews H; Cheung D; Premecz S; Mandal S; Shaikh B; Best R; Bhindi R; Chaudhary R; Ravandi A; Thliveris J; Singal PK; Niraula S; Jassal DS
    Can J Cardiol; 2016 Dec; 32(12):1513-1519. PubMed ID: 27650929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaMKII-dependent SR Ca leak contributes to doxorubicin-induced impaired Ca handling in isolated cardiac myocytes.
    Sag CM; Köhler AC; Anderson ME; Backs J; Maier LS
    J Mol Cell Cardiol; 2011 Nov; 51(5):749-59. PubMed ID: 21819992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Flaxseed and Perindopril in the Prevention of Doxorubicin and Trastuzumab-Induced Cardiotoxicity in C57Bl/6 Mice.
    Eekhoudt CR; Bortoluzzi T; Varghese SS; Cheung DYC; Christie S; Eastman S; Mittal I; Austria JA; Aukema HM; Ravandi A; Thliveris J; Singal PK; Jassal DS
    Curr Oncol; 2022 Apr; 29(5):2941-2953. PubMed ID: 35621631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms.
    Rochette L; Guenancia C; Gudjoncik A; Hachet O; Zeller M; Cottin Y; Vergely C
    Trends Pharmacol Sci; 2015 Jun; 36(6):326-48. PubMed ID: 25895646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vagus nerve stimulation and acetylcholinesterase inhibitor donepezil provide cardioprotection against trastuzumab-induced cardiotoxicity in rats by attenuating mitochondrial dysfunction.
    Khuanjing T; Maneechote C; Ongnok B; Prathumsap N; Arinno A; Chunchai T; Arunsak B; Chattipakorn SC; Chattipakorn N
    Biochem Pharmacol; 2023 Nov; 217():115836. PubMed ID: 37816466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital absence of nitric oxide synthase 3 potentiates cardiac dysfunction and reduces survival in doxorubicin- and trastuzumab-mediated cardiomyopathy.
    Zeglinski M; Premecz S; Lerner J; Wtorek P; Dasilva M; Hasanally D; Chaudhary R; Sharma A; Thliveris J; Ravandi A; Singal PK; Jassal DS
    Can J Cardiol; 2014 Mar; 30(3):359-67. PubMed ID: 24484915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium release near L-type calcium channels promotes beat-to-beat variability in ventricular myocytes from the chronic AV block dog.
    Antoons G; Johnson DM; Dries E; Santiago DJ; Ozdemir S; Lenaerts I; Beekman JD; Houtman MJ; Sipido KR; Vos MA
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):326-34. PubMed ID: 26454162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin induces cardiotoxicity in a pluripotent stem cell model of aggressive B cell lymphoma cancer patients.
    Haupt LP; Rebs S; Maurer W; Hübscher D; Tiburcy M; Pabel S; Maus A; Köhne S; Tappu R; Haas J; Li Y; Sasse A; Santos CCX; Dressel R; Wojnowski L; Bunt G; Möbius W; Shah AM; Meder B; Wollnik B; Sossalla S; Hasenfuss G; Streckfuss-Bömeke K
    Basic Res Cardiol; 2022 Mar; 117(1):13. PubMed ID: 35260914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HER2 inhibitor lapatinib potentiates doxorubicin-induced cardiotoxicity through iNOS signaling.
    Hsu WT; Huang CY; Yen CYT; Cheng AL; Hsieh PCH
    Theranostics; 2018; 8(12):3176-3188. PubMed ID: 29930721
    [No Abstract]   [Full Text] [Related]  

  • 18. Acetylcholine receptor agonists effectively attenuated multiple program cell death pathways and improved left ventricular function in trastuzumab-induced cardiotoxicity in rats.
    Prathumsap N; Ongnok B; Khuanjing T; Arinno A; Maneechote C; Chunchai T; Arunsak B; Kerdphoo S; Chattipakorn SC; Chattipakorn N
    Life Sci; 2023 Sep; 329():121971. PubMed ID: 37482212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diastolic spontaneous calcium release from the sarcoplasmic reticulum increases beat-to-beat variability of repolarization in canine ventricular myocytes after β-adrenergic stimulation.
    Johnson DM; Heijman J; Bode EF; Greensmith DJ; van der Linde H; Abi-Gerges N; Eisner DA; Trafford AW; Volders PG
    Circ Res; 2013 Jan; 112(2):246-56. PubMed ID: 23149594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies.
    Prathumsap N; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Eur J Pharmacol; 2020 Jan; 866():172818. PubMed ID: 31758940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.